Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1016L |
Aviptadil Acetate
醋酸阿肽地尔,阿肽地尔,Vasoactive Intestinal Peptide acetate salt |
RAAS; SARS-CoV | Endocrinology/Hormones; Microbiology/Virology |
Aviptadil Acetate (Vasoactive Intestinal Peptide acetate salt) 是模拟血管活性肠多肽类似物,具有血管舒张效应。它可诱导肺血管舒张并抑制血管 SMC 的增殖和血小板聚集。它可用于研究 SARS-CoV-2 引起的肺纤维化、肺动脉高压和呼吸衰竭。 | |||
TP1016 |
Aviptadil
Vasoactive Intestinal Peptide (human, rat, mouse, rabbit, canine, porcine),阿肽地尔 |
||
Aviptadil (INN) is an analog of vasoactive intestinal polypeptide (VIP) for the treatment of erectile dysfunction. | |||
T80866 |
VIP(Guinea pig) TFA
Vasoactive Intestinal Peptide, guinea pig TFA |
||
VIP Guinea pig TFA,作为一种胃肠激素,兼具神经递质功能,能够刺激胚胎生长,起到营养和有丝分裂因子的作用。 | |||
TP1627L |
Prepro VIP (111-122), human acetate
Prepro VIP (111-122), human acetate(123025-94-5 free base) |
Others | Others |
Prepro VIP (111-122), human acetate(123025-94-5 free base) 是一种前血管活性肠多肽 (VIP) 衍生肽,对应于残基 111-122。 | |||
TP2103L |
[D-p-Cl-Phe6,Leu17]-VIP acetate
|
Others | Others |
[D-p-Cl-Phe6,Leu17]-VIP acetate 是一种竞争性和选择性的血管活性肠肽 (VIP) 受体拮抗剂 (IC50 = 125.8 nM)。 | |||
TP1283L |
VIP(6-28)(human, rat, porcine, bovine) acetate
|
Others | Others |
VIP(6-28)(human, rat, porcine, bovine) acetate 是外源性血管活性肠肽 (VIP) 受体对颈上神经节 (SCG) 中 cAMP 作用的拮抗剂。 | |||
TP2103 |
[D-p-Cl-Phe6,Leu17]-VIP
|
||
Selective vasoactive intestinal peptide (VIP) receptor antagonist (IC50 = 125.8 nM). Displays no activity on glucagon, secretin or GRF receptors. | |||
TP1283 |
VIP(6-28)(human, rat, porcine, bovine)
|
||
VIP(6-28)(human, rat, porcine, bovine) is a potent antagonist that effectively counteracts the effects of exogenous vasoactive intestinal peptide (VIP) on cyclic adenosine monophosphate (cAMP) signaling. | |||
TP1635 |
Prepro VIP (81-122), human
|
||
Prepro VIP (81-122), human is a prepro-vasoactive intestinal polypeptide (VIP) derived peptide, corresponding to residues 81-122. | |||
TP1627 |
Prepro VIP (111-122), human
|
||
Prepro VIP (111-122), human is a prepro-vasoactive intestinal polypeptide (VIP)–derived peptide, corresponding to residues 111-122. | |||
T36635 |
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human)
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) |
||
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) 是GRF的 类似物,是一种血管活性肠肽 (VIP) 拮抗剂。 | |||
T83195 |
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)
|
||
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27),是一种血管活性肠肽,起到VIP1受体拮抗剂的作用。 | |||
T36428 |
PACAP-related Peptide (human) (trifluoroacetate salt)
|
PACAP | GPCR/G Protein |
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adenylate cyclase-activating polypeptide . It is expressed in normal human pancreas and adrenal gland tissue and in some tumors that produce vasoactive intestinal peptide (VIP). PRP (1-29) is secreted by CHO-K1 cells that express human recombinant preproPACAP. | |||
TP1054 |
PACAP (1-38), human, ovine, rat TFA
Pituitary Adenylate Cyclase Activating Polypeptide 38 (TFA) |
||
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), | |||
T80876 |
Vasomera
|
||
Vasomera是一種穩定的長效血管活性腸肽(VIP)激動劑,主要作用於G蛋白偶聯的VPAC2受體,適用於與肌肉營養不良症相關的心肌病研究。 | |||
T82217 |
Helospectin I
|
||
Helospectin I属于血管活性肠肽(VIP)家族的一种神经肽,能够引起血管扩张,具有抗高血压效果,可用于降低血压。该化合物最早是从Heloderma suspectum蜥蜴的唾液腺毒液中分离得到。 | |||
T80069 |
PACAP (6-27) (human, ovine, rat)
Pituitary adenylate cyclase-activating peptide (6-27) |
||
PACAP (6-27) (human, ovine, rat) 是一种对PACAP受体具有拮抗作用的化合物,可以抑制犬肾上腺对外源性VIP的反应。此化合物在心血管疾病和神经系统疾病研究中展现出应用潜力。 | |||
T78003 |
[D-p-Cl-Phe6,Leu17]-VIP TFA
|
||
[D-p-Cl-Phe6,Leu17]-VIP TFA,为竞争性及选择性血管活性肠肽(VIP)受体拮抗剂,其IC50为125.8 nM。该化合物针对胰高血糖素、促胰液素和GRF受体均不表现活性。 | |||
T82216 |
Helospectin II
|
||
Helospectin II,一种属于血管活性肠肽(VIP)家族的神经肽,具备血管扩张作用及抗高血压活性,能够降低血压。该化合物最初从蜥蜴Heloderma suspectum的唾液腺毒液中分离得到。 | |||
T81571 |
PACAP (1-38) free acid TFA
|
||
PACAP (1-38) free acid TFA,一种内源性神经肽,能有效促进胃窦运动,增强体液蛋白分泌,同时抑制胃泌素释放。此外,它刺激血管活性肠肽、胃泌素释放肽和P物质的释放,并通过RACK1增强N-甲基-D-天门冬氨酸受体功能及脑源性神经营养因子表达。 | |||
T78035 |
[K15,R16,L27]VIP(1-7)/GRF(8-27) acetate
|
||
[K15,R16,L27]VIP(1-7)/GRF(8-27)(acetate)为[K15,R16,L27]VIP(1-7)/GRF(8-27)的醋酸盐形态,作为VIP1激动剂,与人类和大鼠的肠血管活性肽1 (VIP 1) 及大鼠的肠血管活性肽2 (VIP 2) 的结合IC50值分别为2 nM、1 nM和30000 nM。 | |||
T81572 |
PACAP (1-38) free acid
|
||
PACAP (1-38) free acid 是一种具有多重生物功能的内源性神经肽,主要作用包括刺激胃窦运动、增进体液蛋白分泌、抑制胃泌素分泌,以及促进血管活性肠肽、胃泌素释放肽和P 物质的释放。此外,PACAP (1-38) free acid 通过与RACK1互作,可以增强N-甲基-D-天门冬氨酸受体的功能并促进脑源性神经营养因子的表达。 |